Terms & Legal
The terms that govern this website, and the notices that actually matter: what this site is, what it is not, and where the technology stands with regulators.
Effective: July 11, 2026 · DeepSensi PBC, Dover, Delaware, USA
This website is operated by DeepSensi PBC, a Delaware public benefit corporation (“DeepSensi”, “we”). By using the site you accept these terms; if you do not accept them, please do not use the site.
Nothing on this website is medical advice, diagnosis, or treatment. The content is general information about a technology and a standard. It does not create a physician–patient relationship, and it is not a substitute for the judgment of a qualified clinician who knows the patient. Never disregard or delay professional medical advice because of something read here. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
The DeepSensi platform is operational software under active validation. It has not been cleared, approved, or certified as a medical device by the U.S. Food and Drug Administration, under the EU Medical Device Regulation, or by any other regulatory authority, and it is not offered to the public for clinical diagnostic use. Regulatory engagement is underway. Wherever the platform operates, it operates as physician-in-the-loop decision support: the supervising clinician holds final authority, and outputs are signed into an auditable record.
Accuracy, safety, and cost figures cited on this site are engineering benchmarks measured on retrospective case collections under the stated conditions, with methodology published in the papers. They are not cleared clinical claims, and retrospective performance does not guarantee performance in clinical use. Where we compare against published third-party results, we cite the source and, where applicable, note protocol differences.
DeepSensi™ is a trademark of DeepSensi PBC (registration applied for). The technologies described here are the subject of pending patent applications and further filings in preparation; “patent-pending” notices on this site refer to that portfolio. Site content is © 2026 DeepSensi PBC; viewing this site grants no license to any patent, trademark, or trade secret. The DeepSensi Standard (DSS) is published separately under open, royalty-free terms described on the Standard page — openness of the standard does not open the platform’s implementation.
You may not use this site unlawfully, misrepresent affiliation with DeepSensi, interfere with the site’s operation, or attempt to gain access to non-public systems or materials (including the documents portal without invitation).
Links to third-party sites and citations of third-party research are provided for reference. We do not control and are not responsible for their content.
Statements about plans, roadmaps, regulatory pathways, and market expectations are forward-looking and may change without notice. Nothing on this website constitutes an offer to sell or a solicitation to buy securities; investor materials are provided separately, under their own access terms, to identified recipients.
The website and its content are provided “as is” and “as available”, without warranties of any kind, express or implied. To the maximum extent permitted by law, DeepSensi PBC and its officers shall not be liable for indirect, incidental, special, or consequential damages arising from use of this website. Nothing here limits liability that cannot be limited by applicable law, nor affects statutory consumer rights where they apply.
These terms are governed by the laws of the State of Delaware, USA, without regard to conflict-of-law rules; if any provision is unenforceable, the remainder stands. We may update these terms by posting a new version here with a new effective date. Questions: [email protected] · Privacy is covered separately in the Privacy notice.